Simultaneous identification of 2-carboxy-tetrahydrocannabinol, tetrahydrocannabinol, cannabinol and cannabidiol in oral fluid

被引:61
|
作者
Moore, Christine [1 ]
Rana, Sumandeep [1 ]
Coulter, Cynthia [1 ]
机构
[1] Immunalysis Corp, Toxicol Res & Dev, Pomona, CA 91767 USA
关键词
oral fluid; tetrahydrocannabinol; cannabinol; cannabidiol; 2-carboxy-THC;
D O I
10.1016/j.jchromb.2007.02.016
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
Tetrahydrocannabinol (THC) is an important psychoactive ingredient in marijuana, which is the most widely used illegal recreational drug in the USA. Since it is generally smoked, the constituents of the plant material, as well as THC may be present in oral fluid specimens collected for the purposes of drug testing. We present an analytical procedure for the simultaneous determination of the pyrolytic precursor Delta(9)-tetrahydrocannabinolic acid A, tetrahydrocannabinol, cannabinol and cannabidiol in human oral fluid specimens using gas chromatography mass spectrometry (GC/MS). Solid phase extraction and GC/MS/EI with selected ion monitoring were used, and the linearity of the method ranged from 0-16 ng/mL of neat oral fluid. The recovery of the cannabinoids from the collection pad into the transportation buffer was greater than 70% for all cannabinoids tested at 4 ng/mL, and the intra- and inter-day precision was less than 10.3 and 15.2% for all analytes. The stability of the drugs in oral fluid and of the extracted derivatives was investigated. The procedure was applied to oral fluid specimens taken from habitual marijuana smokers. We have previously reported the presence of the metabolite 11-nor-Delta(9)-tetra-hydrocannabinol-9-carboxylic acid in oral fluid, but this is the first report of the plant constituent 2-carboxy-THC being detected in saliva. (c) 2007 Elsevier B.V. All rights reserved.
引用
收藏
页码:459 / 464
页数:6
相关论文
共 50 条
  • [41] Urinary pharmacokinetics of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol after controlled oral Δ9-tetrahydrocannabinol administration
    Gustafson, RA
    Kim, I
    Stout, PR
    Klette, KL
    George, MP
    Moolchan, ET
    Levine, B
    Huestis, MA
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2004, 28 (03) : 160 - 167
  • [42] Pharmacokinetic properties of Δ9-tetrahydrocannabinol in serum and oral fluid
    Kauert, Gerold F.
    Ramaekers, Johannes G.
    Schneider, Erhard
    Moeller, Manfred R.
    Toennes, Stefan W.
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2007, 31 (05) : 288 - 293
  • [43] Effects of Oral δ9-Tetrahydrocannabinol and Cannabidiol Combinations on a Sustained Attention Task in Rats
    Moore, Catherine F.
    Davis, Catherine M.
    Sempio, Cristina
    Klawitter, Jost
    Christians, Uwe
    Weerts, Elise M.
    EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, 2023, 31 (05) : 881 - 887
  • [44] Δ9-Tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in human plasma after controlled oral administration of cannabinoids
    Goodivin, Robert S.
    Gustafson, Richard A.
    Barnes, Allan
    Nebro, Wesenyalsh
    Moolchan, Eric T.
    Huestis, Marilyn A.
    THERAPEUTIC DRUG MONITORING, 2006, 28 (04) : 545 - 551
  • [45] EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL, CANNABINOL AND CANNABIDIOL ON THE IMMUNE-SYSTEM IN MICE .2. INVITRO INVESTIGATION USING CULTURED MOUSE SPLENOCYTES
    BACZYNSKY, WOT
    ZIMMERMAN, AM
    PHARMACOLOGY, 1983, 26 (01) : 12 - 19
  • [46] Pharmacokinetic Profile of Δ9-Tetrahydrocannabinol, Cannabidiol, and Metabolites in Blood Following Vaporization and Oral Ingestion of Cannabidiol Products.
    Bergeria, Cecilia L.
    Spindle, Tory R.
    Cone, Edward J.
    Sholler, Dennis
    Goffi, Ella
    Mitchell, John M.
    Winecke, Ruth E.
    Bigelow, George E.
    Flegel, Ronald
    Vandrey, Ryan
    JOURNAL OF ANALYTICAL TOXICOLOGY, 2022, 46 (06) : 583 - 591
  • [47] Simultaneous determination of cannabidiol, cannabinol, and \gD9-tetrahydrocannabinol in human hair by gas chromatography-mass spectrometryin human hair by gas chromatography-mass spectrometry
    Jin Young Kim
    Sung Suh
    Moon Kyo In
    Ki-Jung Paeng
    Bong Chul Chung
    Archives of Pharmacal Research, 2005, 28 : 1086 - 1091
  • [48] COMPARATIVE EFFECTS OF DELTA-9-TETRAHYDROCANNABINOL (DELTA-9-THC), CANNABIDIOL (CBD), AND CANNABINOL (CBN) ON TIMING BEHAVIOR IN RATS
    BORGEN, LA
    SHUMWAY, J
    PHARMACOLOGIST, 1974, 16 (02): : 260 - 260
  • [49] Hypothesized pharmacogenomic and medication influences on tetrahydrocannabinol and cannabidiol metabolism in a cohort of unselected oral cannabis users
    Wright, Jessica A.
    Huang, Linda
    Katamesh, Basant E.
    Yadav, Siddhant
    Singla, Abhinav
    Vincent, Ann
    JOURNAL OF CANNABIS RESEARCH, 2025, 7 (01)
  • [50] A validated method for the simultaneous quantification of cannabidiol, Δ9-tetrahydrocannabinol, and their metabolites in human plasma and application to plasma samples from an oral cannabidiol open-label trial
    Kevin, Richard C.
    Vogel, Rebecca
    Doohan, Peter
    Berger, Maximus
    Amminger, G. Paul
    McGregor, Iain S.
    DRUG TESTING AND ANALYSIS, 2021, 13 (03) : 614 - 627